Get started
Author

John D. Cowan

Terminal sedation in palliative medicine – definition and review of the literature
2001 · John D. Cowan, Declan Walsh · Supportive Care in Cancer · 163
Randomized Trial of Doxorubicin, Bisantrene, and Miltoxantrone in Advanced Breast Cancer: A Southwest Oncology Group Study
1991 · J. D. Cowan, J. Neidhart, et al. · JNCI Journal of the National Cancer Institute · 76
Practical guide to palliative sedation
2002 · John D. Cowan, Teresa W. Palmer · Current Oncology Reports · 74
Phase II study of gemcltablne in patients with metastatic breast cancer
1997 · M. Blackstein, C.L. Vogel, et al. · European Journal of Cancer · 71
Human tumor cloning: Feasibility and clinical correlations
1981 · Daniel D. Von Hoff, John Cowan, et al. · Cancer Chemotherapy and Pharmacology · 71
Hospital charges for a community inpatient palliative care program
2004 · John D. Cowan · American Journal of Hospice and Palliative Medicine® · 46
Simultaneous in vitro drug sensitivity testing on tumors from different sites in the same patient
1986 · Daniel D. Von Hoff, Gary M. Clark, et al. · Cancer · 39
Bone Marrow Necrosis
1980 · John D. Cowan, Ronald N. Rubin, et al. · Cancer · 31
PDF
Phase II trial of five day intravenous infusion vinblastine sulfate in patients with diffuse malignant mesothelioma: A Southwest Oncology Group study
1988 · John D. Cowan, Stephanie Green, et al. · Investigational New Drugs · 27
Palliative medicine in a United States cancer center: A prospective study
2002 · John D. Cowan, Declan Walsh, et al. · American Journal of Hospice and Palliative Medicine® · 23
A randomized trial of doxorubicin, mitoxantrone and bisantrene in advanced breast cancer (A South West Oncology Group Study)
1985 · John D. Cowan, C. Kent Osborne, et al. · Investigational New Drugs · 21
Palliative Sedation in a Southern Appalachian Community
2006 · John D. Cowan, Libby Clemens, et al. · American Journal of Hospice and Palliative Medicine® · 16
A palliative medicine program in a community setting: 12 points from the first 12 months
2003 · John D. Cowan, Debbie Burns, et al. · American Journal of Hospice and Palliative Medicine® · 15
Use of a human tumor cloning system to screen retinoids for antineoplastic activity
1983 · John D. Cowan, Daniel D. Von Hoff, et al. · Cancer · 15
Comparative cytotoxicity of adriamycin, mitoxantrone and bisantrene as measured by a human tumor cloning system
1983 · John D. Cowan, Daniel D. Von Hoff, et al. · Investigational New Drugs · 7
The dying patient
2000 · John D. Cowan · Current Oncology Reports · 6
Predictive Value of Trypan Blue Exclusion Viability Measurements for Colony Formation in a Human Tumor Cloning Assay
1984 · JOHN D. COWAN, DANIEL D. VON HOFF, et al. · Cancer Drug Delivery · 6
Phase II Evaluation of Bisantrene in Acute Leukemia
1989 · Glenn M. Mills, Steve Dahlberg, et al. · American Journal of Clinical Oncology · 5
Palliative Sedation
2009 · John D. Cowan, Teresa Palmer, et al. · Elsevier eBooks · 4
Addison’s Disease Due to Metastatic Carcinoma
1984 · JOHN D. COWAN, MERRILL S. KIES, et al. · Southern Medical Journal · 4
Detection of Recurrent Breast Cancer
1981 · JOHN D. COWAN, MERRILL S. KIES · Southern Medical Journal · 4
Phase II evaluation of bisantrene hydrochloride in refractory malignant melanoma
1987 · David S. Alberts, Nancy Mason-Liddil, et al. · Investigational New Drugs · 3
Experimental Therapy: In Vitro Models
1987 · John D. Cowan, Daniel D. von Hoff · Springer eBooks · 1
Direct Effects of the Hypoxic Cell Sensitizer Misonidazole on Colony Formation in a Human Tumor Cloning Assay
1986 · WERNER SCHEITHAUER, DANIEL D. VON HOFF, et al. · Cancer Drug Delivery · 1
The Human Tumor Cloning Assay: An In Vitro Assay for Antitumor Activity in Solid Tumors
1983 · John D. Cowan, Daniel D. Von Hoff · Cancer treatment and research · 1
Works count: 28
Citation count: 731
H-index: 14
I10-index: 14
Year
Topic
Type